MRSA
Supported pathogenMRSAMethicillin-resistant Staphylococcus aureus
Medicines already documented
Documented evidenceRegistered studies whose listed conditions mention “mrsa”, “methicillin-resistant”, “methicillin resistant”, “staphylococcus aureus”, “staph aureus”.
- Amikacin Sulfate1 registered study
- Aminocaproic Acid1 registered study
- Argatroban1 registered study
- Aztreonam1 registered study
- Bacitracin2 registered studies
- Cefazolin Sodium4 registered studies
- Cefepime Hydrochloride2 registered studies
- Cefoxitin Sodium1 registered study
- Ceftaroline Fosamil3 registered studies
- Cephalexin1 registered study
- Chloramphenicol1 registered study
- Chlorhexidine Gluconate2 registered studies
- Cidofovir1 registered study
- Cilastatin Sodium1 registered study
- Ciprofloxacin1 registered study
- Clarithromycin1 registered study
- Clindamycin Hydrochloride5 registered studies
- Clindamycin Phosphate1 registered study
Show all 46
- Cloxacillin Sodium11 registered studies
- Cysteine Hydrochloride1 registered study
- Daptomycin9 registered studies
- Dicloxacillin Sodium1 registered study
- Doxycycline1 registered study
- Ertapenem Sodium2 registered studies
- Erythromycin1 registered study
- Hexachlorophene2 registered studies
- Kanamycin Sulfate1 registered study
- Labetalol Hydrochloride1 registered study
- Lincomycin Hydrochloride4 registered studies
- Linezolid2 registered studies
- Methicillin Sodium24 registered studies
- Minocycline Hydrochloride1 registered study
- Molindone Hydrochloride1 registered study
- Mupirocin19 registered studies
- Nafcillin Sodium4 registered studies
- Oxacillin Sodium9 registered studies
- Pentobarbital1 registered study
- Retapamulin4 registered studies
- Rifabutin1 registered study
- Rifampin1 registered study
- Sodium Gluconate2 registered studies
- Sulfamethoxazole5 registered studies
- Triclosan2 registered studies
- Trovafloxacin Mesylate1 registered study
- Vancomycin2 registered studies
- Vecuronium Bromide1 registered study
Laboratory measurements against MRSA recorded in ChEMBL.
- Acetohydroxamic Acidmeasured active in 0 of 1 lab record
- Amdinocillinmeasured active in 0 of 1 lab record
- Amikacin Sulfatemeasured active in 1 of 1 lab record
- Amoxicillinmeasured active in 20 of 26 lab records
- Ampicillin Sodiummeasured active in 5 of 20 lab records
- Azithromycinmeasured active in 7 of 9 lab records
- Azlocillin Sodiummeasured active in 1 of 1 lab record
- Capreomycin Sulfatemeasured active in 0 of 1 lab record
- Carbenicillin Disodiummeasured active in 3 of 5 lab records
- Cefaclormeasured active in 10 of 15 lab records
- Cefdinirmeasured active in 2 of 2 lab records
- Cefotaxime Sodiummeasured active in 11 of 16 lab records
- Cefoxitin Sodiummeasured active in 5 of 10 lab records
- Cefprozilmeasured active in 2 of 2 lab records
- Ceftazidimemeasured active in 5 of 5 lab records
- Ceftriaxone Sodiummeasured active in 8 of 8 lab records
- Cefuroxime Sodiummeasured active in 6 of 6 lab records
- Cephalexinmeasured active in 4 of 7 lab records
Show all 74
- Cephalothin Sodiummeasured active in 4 of 4 lab records
- Cetyl Alcoholmeasured active in 0 of 1 lab record
- Chloramphenicolmeasured active in 0 of 3 lab records
- Chlorhexidine Gluconatemeasured active in 1 of 1 lab record
- Choline C-11measured active in 0 of 1 lab record
- Ciprofloxacinmeasured active in 118 of 130 lab records
- Clarithromycinmeasured active in 10 of 12 lab records
- Clavulanate Potassiummeasured active in 1 of 8 lab records
- Dactinomycinmeasured active in 1 of 1 lab record
- Dalbavancin Hydrochloridemeasured active in 1 of 1 lab record
- Dalfopristinmeasured active in 1 of 1 lab record
- Daunorubicin Citratemeasured active in 2 of 2 lab records
- Doxorubicin Hydrochloridemeasured active in 0 of 1 lab record
- Doxycyclinemeasured active in 1 of 1 lab record
- Enoxacinmeasured active in 9 of 9 lab records
- Erythromycinmeasured active in 17 of 25 lab records
- Ethacrynic Acidmeasured active in 0 of 1 lab record
- Gatifloxacinmeasured active in 3 of 3 lab records
- Gemifloxacin Mesylatemeasured active in 4 of 4 lab records
- Grepafloxacin Hydrochloridemeasured active in 2 of 2 lab records
- Hexachlorophenemeasured active in 6 of 6 lab records
- Imipenemmeasured active in 44 of 77 lab records
- Kanamycin Sulfatemeasured active in 1 of 11 lab records
- Levofloxacinmeasured active in 1 of 1 lab record
- Lincomycin Hydrochloridemeasured active in 2 of 3 lab records
- Linezolidmeasured active in 39 of 44 lab records
- Lomefloxacin Hydrochloridemeasured active in 3 of 3 lab records
- Meropenemmeasured active in 16 of 17 lab records
- Methicillin Sodiummeasured active in 8 of 26 lab records
- Metronidazolemeasured active in 0 of 1 lab record
- Mezlocillin Sodium Monohydratemeasured active in 2 of 5 lab records
- Minocycline Hydrochloridemeasured active in 4 of 4 lab records
- Mupirocinmeasured active in 6 of 10 lab records
- Nafcillin Sodiummeasured active in 4 of 7 lab records
- Nalidixic Acidmeasured active in 0 of 5 lab records
- Norfloxacinmeasured active in 45 of 47 lab records
- Ofloxacinmeasured active in 26 of 27 lab records
- Oritavancin Diphosphatemeasured active in 2 of 2 lab records
- Oxacillin Sodiummeasured active in 9 of 22 lab records
- Paromomycin Sulfatemeasured active in 1 of 1 lab record
- Penicillin G Sodiummeasured active in 6 of 10 lab records
- Penicillin Vmeasured active in 2 of 3 lab records
- Piperacillin Sodiummeasured active in 6 of 12 lab records
- Rifampinmeasured active in 3 of 3 lab records
- Rifamycin Sodiummeasured active in 2 of 2 lab records
- Sparfloxacinmeasured active in 5 of 5 lab records
- Streptomycin Sulfatemeasured active in 2 of 2 lab records
- Sulbactam Sodiummeasured active in 2 of 5 lab records
- Tazobactam Sodiummeasured active in 2 of 2 lab records
- Telithromycinmeasured active in 9 of 11 lab records
- Tetracycline Hydrochloridemeasured active in 2 of 2 lab records
- Tobramycinmeasured active in 3 of 10 lab records
- Triclosanmeasured active in 2 of 2 lab records
- Trimethoprimmeasured active in 7 of 8 lab records
- Trovafloxacin Mesylatemeasured active in 0 of 1 lab record
- Vancomycinmeasured active in 103 of 103 lab records
Other medicines to investigate
AI prediction · nothing measuredApproved medicines with AI-predicted activity ≥40% against MRSA that are not already antimicrobials, have no registered study for this condition and have no laboratory record against it. Each shows what it is already used for. They were surfaced computationally for further investigation and are not presented as established treatments for this condition.
MRSA has 671 repurposing candidates in all. 7 are already listed above, with a registered study for this condition or a laboratory record, so the other 664 are listed here.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- KetoconazoleExisting use: Adrenal gland disease, Blastomycosis, Cushing syndrome and 3 more63.6% AI-predicted activityagainst MRSA50+ registered studies
- LevoketoconazoleExisting use: Adrenal gland disease, Adrenal gland hyperfunction, Cushing syndrome63.6% AI-predicted activityagainst MRSA6 registered studies
- Nafarelin AcetateExisting use: Endometriosis63.6% AI-predicted activityagainst MRSA12 registered studies
- Pafolacianine SodiumExisting use: Other diagnostic agents63.6% AI-predicted activityagainst MRSA1 registered study
- Vinorelbine TartrateExisting use: Cancer, Neoplasm63.6% AI-predicted activityagainst MRSA50+ registered studies
- Ibrexafungerp CitrateExisting use: Vulvovaginal candidiasis63.5% AI-predicted activityagainst MRSANo documented evidence found
- Gonadorelin AcetateExisting use: Gonadotropin-releasing hormones, Tests for fertility disturbances63.4% AI-predicted activityagainst MRSA50+ registered studies
- Icatibant AcetateExisting use: Angioedema, Hereditary angioedema63.4% AI-predicted activityagainst MRSA33 registered studies
- LonafarnibExisting use: Hutchinson-Gilford progeria syndrome, Laminopathies, Progeria63.3% AI-predicted activityagainst MRSA39 registered studies
- LypressinExisting use: Vasopressin and analogues63.2% AI-predicted activityagainst MRSA50+ registered studies
- Cetrorelix AcetateExisting use: Ovulation Inhibition, Positive regulation of ovulation63.2% AI-predicted activityagainst MRSA50+ registered studies
- LorlatinibExisting use: Cancer, Lymphoma, Neoplasm and 1 more63.1% AI-predicted activityagainst MRSA50+ registered studies
Every repurposing candidate for MRSA, including those with documented evidence →
Registered studies
A registration describes a study; it does not establish a positive result.
Two Strategies for Methicillin-resistant Staphylococcus Aureus (MRSA) Infection Prevention in Surgical Patients
NCT00685867 · start 2008-05
Registered record
- Registry ID
- NCT00685867
- Conditions
- MRSA Infection
- Interventions
- Rapid molecular MRSA test; Hand hygiene promotion
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2008-05
- Completion
- 2010-12
- Enrolment
- 126,750
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMRSA InfectionInterventionRapid molecular MRSA test; Hand hygiene promotionPhaseNot applicableRegistry statusCompletedComparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx
NCT00713674 · start 2008-03
Registered record
- Registry ID
- NCT00713674
- Conditions
- Methicillin-Resistant Staphylococcus Aureus
- Interventions
- Theraworx; mupirocin antibiotic ointment
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Withdrawn
- Start
- 2008-03
- Completion
- 2009-02
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMethicillin-Resistant Staphylococcus AureusInterventionTheraworx; mupirocin antibiotic ointmentPhaseNot applicableRegistry statusWithdrawnA Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
NCT00532324 · start 2008-02
Registered record
- Registry ID
- NCT00532324
- Conditions
- Staphylococcus Aureus
- Interventions
- CA-MRSA Decolonization
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2008-02
- Completion
- 2013-10
- Enrolment
- 107
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionStaphylococcus AureusInterventionCA-MRSA DecolonizationPhaseNot applicableRegistry statusCompletedIncidence and Relationship of Positive Preoperative Methicillin Resistant Staphylococcus Aureus (MRSA) Screens and Post-operative Infections
NCT01028105 · start 2008-02
Registered record
- Registry ID
- NCT01028105
- Conditions
- Methicillin-resistant Staphylococcus Aureus Infection
- Interventions
- Preoperative MRSA screening
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Terminated
- Start
- 2008-02
- Completion
- 2013-10
- Enrolment
- 975
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMethicillin-resistant Staphylococcus Aureus InfectionInterventionPreoperative MRSA screeningPhaseNot applicableRegistry statusTerminatedVancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis
NCT00967941 · start 2007-08
Registered record
- Registry ID
- NCT00967941
- Conditions
- MRSA Infections
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2007-08
- Completion
- 2010-08
- Enrolment
- 169
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMRSA InfectionsInterventionNot recordedPhaseNot recordedRegistry statusCompletedA Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection
NCT00560599 · start 2007-04
Registered record
- Registry ID
- NCT00560599
- Conditions
- Methicillin Resistant Staphylococcus Aureus Skin Infections
- Interventions
- mupirocin and chlorhexidine; household cleaning and disinfection; mupirocin, chlorhexidine, & household cleaning/disinfection
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2007-04
- Completion
- 2012-12
- Enrolment
- 350
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMethicillin Resistant Staphylococcus Aureus Skin InfectionsInterventionmupirocin and chlorhexidine; household cleaning and disinfection; mupirocin, chlorhexidine, & household cleaning/disinfectionPhasePhase 3Registry statusCompletedThe Natural History of Community-Associated MRSA Infections and Decolonization Strategies
NCT00513799 · start 2007-03
Registered record
- Registry ID
- NCT00513799
- Conditions
- Abscesses; Furunculosis; Staphylococcus Aureus; Staphylococcal Skin Infections
- Interventions
- Mupirocin ointment; Chlorhexidine showers; Bleach baths (dilute); Intensive education on personal hygiene
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2007-03
- Completion
- 2010-12
- Enrolment
- 300
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAbscesses; Furunculosis; Staphylococcus Aureus; Staphylococcal Skin InfectionsInterventionMupirocin ointment; Chlorhexidine showers; Bleach baths (dilute); Intensive education on personal hygienePhaseNot applicableRegistry statusCompletedA Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections
NCT01049438 · start 2006-08
Registered record
- Registry ID
- NCT01049438
- Conditions
- Methicillin Resistant Staphylococcus Aureus Skin Infections
- Interventions
- nasal mupirocin; topical 3% hexachlorophene body wash; oral anti-MRSA antibiotic
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2006-08
- Completion
- 2009-09
- Enrolment
- 31
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMethicillin Resistant Staphylococcus Aureus Skin InfectionsInterventionnasal mupirocin; topical 3% hexachlorophene body wash; oral anti-MRSA antibioticPhaseNot applicableRegistry statusCompletedAn Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers
NCT00289588 · start 2005-01
Registered record
- Registry ID
- NCT00289588
- Conditions
- Community-Acquired MRSA Infections; Abscesses; Cellulitis; Folliculitis
- Interventions
- Mupirocin (drug)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2005-01
- Completion
- 2005-12
- Enrolment
- 3,000
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCommunity-Acquired MRSA Infections; Abscesses; Cellulitis; FolliculitisInterventionMupirocin (drug)PhaseNot applicableRegistry statusCompletedNosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
NCT00084266 · start 2004-10
Registered record
- Registry ID
- NCT00084266
- Conditions
- Methicillin Resistant Staphylococcus Aureus (MRSA)
- Interventions
- linezolid (Zyvox); vancomycin
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2004-10
- Completion
- 2010-03
- Enrolment
- 1,225
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMethicillin Resistant Staphylococcus Aureus (MRSA)Interventionlinezolid (Zyvox); vancomycinPhasePhase 4Registry statusCompletedSkin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
NCT00087490 · start 2004-10
Registered record
- Registry ID
- NCT00087490
- Conditions
- Skin/Soft Tissue Infections; Methicillin Resistant Staphylococcus Aureus (MRSA)
- Interventions
- linezolid; vancomycin
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2004-10
- Completion
- 2007-07
- Enrolment
- 1,077
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSkin/Soft Tissue Infections; Methicillin Resistant Staphylococcus Aureus (MRSA)Interventionlinezolid; vancomycinPhasePhase 4Registry statusCompletedCefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia
NCT07186894 · start 2000-01-01
Registered record
- Registry ID
- NCT07186894
- Conditions
- Bacteriemia; Methicillin Susceptible Staphylococcus Aureus (MSSA) Infection
- Interventions
- Antistaphylococcal penicillins; Cefazolin
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Active not recruiting
- Start
- 2000-01-01
- Completion
- 2026-09-01
- Enrolment
- 5,000
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBacteriemia; Methicillin Susceptible Staphylococcus Aureus (MSSA) InfectionInterventionAntistaphylococcal penicillins; CefazolinPhaseNot recordedRegistry statusActive not recruitingCombination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
NCT00548002 · start 1999-01
Registered record
- Registry ID
- NCT00548002
- Conditions
- Staphylococcus Aureus; Bacteremia; Endocarditis; Sepsis
- Interventions
- trovafloxacin and levofloxacin
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 1999-01
- Completion
- 2002-08
- Enrolment
- 430
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionStaphylococcus Aureus; Bacteremia; Endocarditis; SepsisInterventiontrovafloxacin and levofloxacinPhaseNot recordedRegistry statusCompleted